Detection of Hypertrophic Cardiomyopathy Using a Convolutional Neural Network-Enabled Electrocardiogram.

[1]  Rickey E. Carter,et al.  Screening for cardiac contractile dysfunction using an artificial intelligence–enabled electrocardiogram , 2019, Nature Medicine.

[2]  Mathew G. Wilson,et al.  Impact of geographical origin upon the electrical and structural manifestations of the black athlete’s heart , 2018, European heart journal.

[3]  Pablo Laguna,et al.  Distinct ECG Phenotypes Identified in Hypertrophic Cardiomyopathy Using Machine Learning Associate With Arrhythmic Risk Markers , 2018, Front. Physiol..

[4]  B. Gersh,et al.  Women with hypertrophic cardiomyopathy have worse survival , 2017, European heart journal.

[5]  T. Knilans,et al.  Pilot study analyzing automated ECG screening of hypertrophic cardiomyopathy. , 2017, Heart rhythm.

[6]  H. Naci,et al.  Cost Implications of Using Different ECG Criteria for Screening Young Athletes in the United Kingdom. , 2016, Journal of the American College of Cardiology.

[7]  Hagit Shatkay,et al.  Utilizing ECG-Based Heartbeat Classification for Hypertrophic Cardiomyopathy Identification , 2015, IEEE Transactions on NanoBioscience.

[8]  Barry J Maron,et al.  New perspectives on the prevalence of hypertrophic cardiomyopathy. , 2015, Journal of the American College of Cardiology.

[9]  J. Kalman,et al.  Modest agreement in ECG interpretation limits the application of ECG screening in young athletes. , 2015, Heart rhythm.

[10]  V. Froelicher,et al.  Comparison of three ECG criteria for athlete pre-participation screening. , 2014, Journal of electrocardiology.

[11]  J. Saul,et al.  Assessment of the 12-lead ECG as a screening test for detection of cardiovascular disease in healthy general populations of young people (12-25 Years of Age): a scientific statement from the American Heart Association and the American College of Cardiology. , 2014, Circulation.

[12]  Paul Kligfield,et al.  Assessment of the 12-Lead Electrocardiogram as a Screening Test for Detection of Cardiovascular Disease in Healthy General Populations of Young People (12 – 25 Years of Age) , 2014 .

[13]  B. Gersh,et al.  Atrial Fibrillation in Hypertrophic Cardiomyopathy: Prevalence, Clinical Correlations, and Mortality in a Large High‐Risk Population , 2014, Journal of the American Heart Association.

[14]  B. Maron,et al.  Incidence and causes of sudden death in U.S. college athletes. , 2014, Journal of the American College of Cardiology.

[15]  Mathew G. Wilson,et al.  Comparison of Electrocardiographic Criteria for the Detection of Cardiac Abnormalities in Elite Black and White Athletes , 2014, Circulation.

[16]  Hein Heidbuchel,et al.  Electrocardiographic interpretation in athletes: the ‘Seattle Criteria’ , 2013, British Journal of Sports Medicine.

[17]  M. Link,et al.  Significance of false negative electrocardiograms in preparticipation screening of athletes for hypertrophic cardiomyopathy. , 2012, The American journal of cardiology.

[18]  Barry J Maron,et al.  2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, American Soci , 2011, Journal of the American College of Cardiology.

[19]  E. Ashley,et al.  Interpretation of the Electrocardiogram of Young Athletes , 2011, Circulation.

[20]  Barry J Maron,et al.  2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2011, Journal of the American College of Cardiology.

[21]  E. Ashley,et al.  Cost-Effectiveness of Preparticipation Screening for Prevention of Sudden Cardiac Death in Young Athletes , 2010, Annals of Internal Medicine.

[22]  Barry J Maron,et al.  Recommendations for interpretation of 12-lead electrocardiogram in the athlete. , 2009, European heart journal.

[23]  A. Tajik,et al.  Outcome of patients with hypertrophic cardiomyopathy and a normal electrocardiogram. , 2009, Journal of the American College of Cardiology.

[24]  M. Link,et al.  Gender-related differences in the clinical presentation and outcome of hypertrophic cardiomyopathy. , 2005, Journal of the American College of Cardiology.

[25]  C. Wren.  Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol. , 2005, European heart journal.

[26]  B. Maron,et al.  Clinical significance of abnormal electrocardiographic patterns in trained athletes. , 2000, Circulation.

[27]  N. Ouyang,et al.  Using a neural network to diagnose the hypertrophic portions of hypertrophic cardiomyopathy. , 1998, M.D. computing : computers in medical practice.

[28]  J. Gardin,et al.  Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. , 1995, Circulation.